dr. zandberg on durvalumab trial in head and neck cancer
Published 6 years ago • 97 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:02
dr. zandberg on the role of durvalumab in head and neck cancer
-
0:54
dr. zandberg on the role of immunotherapy in head and neck cancer
-
0:44
dr. zandberg on biomarker development in head and neck cancer
-
1:08
dr. zandburg on biomarker development in head and neck cancer
-
1:42
dr. feldman on the future of durvalumab and tremilimumab in nsclc
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
1:08
dr. bazhenova on the pacific trial with durvalumab in nsclc
-
2:00
durvalumab plus danvatirsen for r/m hnscc: exciting scores data
-
1:00
trial of durvalumab for bladder cancer
-
1:37
results for durvalumab in the second-line treatment of nsclc
-
1:32
dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
-
6:38
pacific trial of durvalumab for lung cancer
-
1:20
dr. simon on durvalumab for patients with lung cancer
-
2:10
poseidon: 4 year follow up of durvalumab and tremelimumab in nsclc
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
1:00
dr. joshi on durvalumab and radiation therapy in locally advanced urothelial cancer of the bladder